• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定出 SARS-CoV-2 nsp6 羧基末端的一个膜相关元件(MAE),该元件对病毒复制是必需的。

Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.

机构信息

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, and Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

出版信息

J Virol. 2024 May 14;98(5):e0034924. doi: 10.1128/jvi.00349-24. Epub 2024 Apr 19.

DOI:10.1128/jvi.00349-24
PMID:38639488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11092323/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel coronavirus severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has rapidly spread worldwide since its emergence in late 2019. Its ongoing evolution poses challenges for antiviral drug development. Coronavirus nsp6, a multiple-spanning transmembrane protein, participates in the biogenesis of the viral replication complex, which accommodates the viral replication-transcription complex. The roles of its structural domains in viral replication are not well studied. Herein, we predicted the structure of the SARS-CoV-2 nsp6 protein using AlphaFold2 and identified a highly folded C-terminal region (nsp6C) downstream of the transmembrane helices. The enhanced green fluorescent protein (EGFP)-fused nsp6C was found to cluster in the cytoplasm and associate with membranes. Functional mapping identified a minimal membrane-associated element (MAE) as the region from amino acids 237 to 276 (LGV-KLL), which is mainly composed of the α-helix H1 and the α-helix H2; the latter exhibits characteristics of an amphipathic helix (AH). Mutagenesis studies and membrane flotation experiments demonstrate that AH-like H2 is required for MAE-mediated membrane association. This MAE was functionally conserved across MERS-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, and HCoV-NL63, all capable of mediating membrane association. In a SARS-CoV-2 replicon system, mutagenesis studies of H2 and replacements of H1 and H2 with their homologous counterparts demonstrated requirements of residues on both sides of the H2 and properly paired H1-H2 for MAE-mediated membrane association and viral replication. Notably, mutations I266A and K274A significantly attenuated viral replication without dramatically affecting membrane association, suggesting a dual role of the MAE in viral replication: mediating membrane association as well as participating in protein-protein interactions.IMPORTANCESevere acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) assembles a double-membrane vesicle (DMV) by the viral non-structural proteins for viral replication. Understanding the mechanisms of the DMV assembly is of paramount importance for antiviral development. Nsp6, a multiple-spanning transmembrane protein, plays an important role in the DMV biogenesis. Herein, we predicted the nsp6 structure of SARS-CoV-2 and other human coronaviruses using AlphaFold2 and identified a putative membrane-associated element (MAE) in the highly conserved C-terminal regions of nsp6. Experimentally, we verified a functionally conserved minimal MAE composed of two α-helices, the H1, and the amphipathic helix-like H2. Mutagenesis studies confirmed the requirement of H2 for MAE-mediated membrane association and viral replication and demonstrated a dual role of the MAE in viral replication, by mediating membrane association and participating in residue-specific interactions. This functionally conserved MAE may serve as a novel anti-viral target.

摘要

新型冠状病毒病 2019(COVID-19)疫情由新型冠状病毒严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起,自 2019 年底出现以来已迅速在全球蔓延。其持续进化给抗病毒药物的开发带来了挑战。冠状病毒 nsp6 是一种多跨膜蛋白,参与病毒复制复合物的生物发生,该复合物容纳病毒复制-转录复合物。其结构域在病毒复制中的作用尚未得到很好的研究。在此,我们使用 AlphaFold2 预测了 SARS-CoV-2 nsp6 蛋白的结构,并鉴定出跨膜螺旋下游具有高度折叠的 C 末端区域(nsp6C)。发现融合增强型绿色荧光蛋白(EGFP)的 nsp6C 在细胞质中聚集并与膜结合。功能映射确定了一个最小的膜相关元件(MAE)作为氨基酸 237 到 276(LGV-KLL)的区域,该区域主要由α-螺旋 H1 和α-螺旋 H2 组成;后者表现出两性螺旋(AH)的特征。突变和膜浮选实验表明,AH 样 H2 是 MAE 介导的膜结合所必需的。该 MAE 在 MERS-CoV、HCoV-OC43、HCoV-229E、HCoV-HKU1 和 HCoV-NL63 中均具有功能保守性,这些病毒均能够介导膜结合。在 SARS-CoV-2 复制子系统中,对 H2 的突变研究以及用同源物替代 H1 和 H2,表明 H2 两侧的残基以及正确配对的 H1-H2 对于 MAE 介导的膜结合和病毒复制都是必需的。值得注意的是,I266A 和 K274A 突变显著削弱了病毒复制,而对膜结合没有明显影响,这表明 MAE 在病毒复制中具有双重作用:介导膜结合以及参与蛋白质-蛋白质相互作用。重要性:严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)通过病毒非结构蛋白组装双膜囊泡(DMV)进行病毒复制。了解 DMV 组装的机制对于抗病毒药物的开发至关重要。nsp6 是一种多跨膜蛋白,在 DMV 生物发生中发挥重要作用。在此,我们使用 AlphaFold2 预测了 SARS-CoV-2 和其他人类冠状病毒的 nsp6 结构,并在 nsp6 的高度保守 C 末端区域鉴定出一个假定的膜相关元件(MAE)。实验验证了一个由两个α-螺旋,H1 和类两性螺旋的 H2 组成的具有功能保守性的最小 MAE。突变研究证实了 H2 对于 MAE 介导的膜结合和病毒复制的必要性,并证明了 MAE 在病毒复制中的双重作用,通过介导膜结合和参与特定残基的相互作用。这个具有功能保守性的 MAE 可能成为一种新型的抗病毒靶点。

相似文献

1
Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.鉴定出 SARS-CoV-2 nsp6 羧基末端的一个膜相关元件(MAE),该元件对病毒复制是必需的。
J Virol. 2024 May 14;98(5):e0034924. doi: 10.1128/jvi.00349-24. Epub 2024 Apr 19.
2
Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.SARS-CoV-2 nsp3 的 C 末端和跨膜区的寡聚组装。
J Virol. 2024 Apr 16;98(4):e0157523. doi: 10.1128/jvi.01575-23. Epub 2024 Mar 14.
3
Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication.表达和切割中东呼吸综合征冠状病毒 nsp3-4 多蛋白可诱导形成双层囊泡,这些囊泡模拟与冠状病毒 RNA 复制相关的囊泡。
mBio. 2017 Nov 21;8(6):e01658-17. doi: 10.1128/mBio.01658-17.
4
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle.NSP6 在 SARS-CoV-2 复制细胞器生物发生中的作用。
Nature. 2022 Jun;606(7915):761-768. doi: 10.1038/s41586-022-04835-6. Epub 2022 May 12.
5
Oxysterole-binding protein targeted by SARS-CoV-2 viral proteins regulates coronavirus replication.SARS-CoV-2 病毒蛋白靶向的氧化固醇结合蛋白调节冠状病毒复制。
Front Cell Infect Microbiol. 2024 Jul 25;14:1383917. doi: 10.3389/fcimb.2024.1383917. eCollection 2024.
6
Properties of Coronavirus and SARS-CoV-2.冠状病毒及新型冠状病毒(SARS-CoV-2)的特性
Malays J Pathol. 2020 Apr;42(1):3-11.
7
SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein.SARS-CoV-2 的非结构蛋白 6 从 Alpha 到奥密克戎:一种跨膜蛋白的进化。
mBio. 2023 Aug 31;14(4):e0068823. doi: 10.1128/mbio.00688-23. Epub 2023 Jul 21.
8
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.吸入性类固醇 Ciclesonide 通过靶向细胞培养中的病毒复制转录复合物来阻断 SARS-CoV-2 RNA 复制。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01648-20.
9
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.SARS-CoV-2 与同源冠状病毒非结构蛋白的比较多重相互作用组学鉴定了独特和共享的宿主细胞依赖性。
ACS Infect Dis. 2020 Dec 11;6(12):3174-3189. doi: 10.1021/acsinfecdis.0c00500. Epub 2020 Dec 2.
10
A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.一种符合 BSL-2 标准的 SARS-CoV-2 感染的小鼠模型,用于高效便捷地评估抗病毒药物。
J Virol. 2024 Jul 23;98(7):e0050424. doi: 10.1128/jvi.00504-24. Epub 2024 Jun 20.

引用本文的文献

1
NSP6 regulates calcium overload-induced autophagic cell death and is regulated by KLHL22-mediated ubiquitination.NSP6调节钙超载诱导的自噬性细胞死亡,并受KLHL22介导的泛素化作用调控。
J Adv Res. 2025 Aug;74:303-318. doi: 10.1016/j.jare.2025.05.031. Epub 2025 May 13.
2
Coronavirus nucleocapsid protein enhances the binding of p-PKCα to RACK1: Implications for inhibition of nucleocytoplasmic trafficking and suppression of the innate immune response.冠状病毒核衣壳蛋白增强p-PKCα与RACK1的结合:对抑制核质运输和抑制先天免疫反应的影响。
PLoS Pathog. 2024 Nov 27;20(11):e1012097. doi: 10.1371/journal.ppat.1012097. eCollection 2024 Nov.

本文引用的文献

1
SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle.SARS-CoV-2 的 nsp3 和 nsp4 是一种跨膜复制细胞器的最小组成部分。
Nat Commun. 2023 Nov 30;14(1):7894. doi: 10.1038/s41467-023-43666-5.
2
SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein.SARS-CoV-2 的非结构蛋白 6 从 Alpha 到奥密克戎:一种跨膜蛋白的进化。
mBio. 2023 Aug 31;14(4):e0068823. doi: 10.1128/mbio.00688-23. Epub 2023 Jul 21.
3
SARS-CoV-2 neutralising antibody therapies: Recent advances and future challenges.SARS-CoV-2 中和抗体疗法:最新进展与未来挑战。
Rev Med Virol. 2023 Sep;33(5):e2464. doi: 10.1002/rmv.2464. Epub 2023 Jun 15.
4
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6.SARS-CoV-2 基因组的快速组装揭示了 NSP6 导致奥密克戎 BA.1 变体衰减。
Nat Commun. 2023 Apr 21;14(1):2308. doi: 10.1038/s41467-023-37787-0.
5
The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2.nsp6 在 SARS-CoV-2 分子发病机制中的多重作用。
Antiviral Res. 2023 May;213:105590. doi: 10.1016/j.antiviral.2023.105590. Epub 2023 Mar 31.
6
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation.刺突蛋白和非结构蛋白6是新冠病毒奥密克戎BA.1毒株致病性减弱的关键决定因素。
Nature. 2023 Mar;615(7950):143-150. doi: 10.1038/s41586-023-05697-2. Epub 2023 Jan 11.
7
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.对 COVID-19 目前进展的批判性综述:疫苗、抗病毒药物和治疗性抗体的开发。
J Biomed Sci. 2022 Sep 12;29(1):68. doi: 10.1186/s12929-022-00852-9.
8
A conserved viral amphipathic helix governs the replication site-specific membrane association.一种保守的病毒两亲性螺旋结构决定了复制位点特异性的膜结合。
PLoS Pathog. 2022 Sep 1;18(9):e1010752. doi: 10.1371/journal.ppat.1010752. eCollection 2022 Sep.
9
SARS-CoV-2's Variants of Concern: A Brief Characterization.SARS-CoV-2 的关注变异株:简要特征描述。
Front Immunol. 2022 Jul 26;13:834098. doi: 10.3389/fimmu.2022.834098. eCollection 2022.
10
In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing.基于计算机的 SARS-CoV-2 NSP6 靶向治疗用于药物和天然产物的再利用。
Virology. 2022 Aug;573:96-110. doi: 10.1016/j.virol.2022.06.008. Epub 2022 Jun 15.